Search

Your search keyword '"PPAR alpha physiology"' showing total 436 results

Search Constraints

Start Over You searched for: Descriptor "PPAR alpha physiology" Remove constraint Descriptor: "PPAR alpha physiology"
436 results on '"PPAR alpha physiology"'

Search Results

1. PPAR agonists for the treatment of neuroinflammatory diseases.

2. Fasudil mediates neuroprotection in ischemia/reperfusion by modulating the ROCK-PPARα-NOX axis.

3. Metabolomics Reveals Gut Microbiota Contribute to PPARα Deficiency-Induced Alcoholic Liver Injury.

4. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.

5. Ablation of Selenbp1 Alters Lipid Metabolism via the Pparα Pathway in Mouse Kidney.

6. Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha).

7. PPARα/RXRα downregulates amino acid catabolism in the liver via interaction with HNF4α promoting its proteasomal degradation.

8. Bilirubin as a metabolic hormone: the physiological relevance of low levels.

9. [PPARα-Ligand Binding Modes Revealed by X-ray Crystallography].

10. PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction.

11. Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin.

12. GPR119 Is a Potent Regulator of Human Sebocyte Biology.

13. Moderate aerobic exercise-induced cytokines changes are disturbed in PPARα knockout mice.

14. The critical role of PPARα in the binary switch between life and death induced by endoplasmic reticulum stress.

15. Energy Metabolism in Cellular Regenerative Processes: Focus on PPARα.

16. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.

17. M3 muscarinic receptor activation reduces hepatocyte lipid accumulation via CaMKKβ/AMPK pathway.

18. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.

19. Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.

21. Stimulation of Peroxisome Proliferator-Activated Receptor-α by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior.

22. Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPARα.

23. Hepatic PPARα is critical in the metabolic adaptation to sepsis.

24. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.

25. Opposing Effects of PPARα Agonism and Antagonism on Refractive Development and Form Deprivation Myopia in Guinea Pigs.

26. Suppression of abdominal fat and anti-hyperlipidemic potential of Emblica officinalis: Upregulation of PPARs and identification of active moiety.

27. Pparα deficiency inhibits the proliferation of neuronal and glial precursors in the zebrafish central nervous system.

28. Role of peroxisome proliferator-activated receptor alpha (PPARα) and PPARα-mediated species differences in triclosan-induced liver toxicity.

29. A role for peroxisome proliferator-activated receptor α in anticonvulsant activity of docosahexaenoic acid against seizures induced by pentylenetetrazole.

30. PPARα Mediates the Hepatoprotective Effects of Nutmeg.

31. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.

32. PPARα Is Necessary for Radiation-Induced Activation of Noncanonical TGFβ Signaling in the Heart.

33. Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate.

34. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.

35. A Phytol-Enriched Diet Activates PPAR-α in the Liver and Brown Adipose Tissue to Ameliorate Obesity-Induced Metabolic Abnormalities.

36. Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People.

37. Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.

38. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.

39. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.

40. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.

41. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

42. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.

43. The Role of Nuclear Receptor PPARα in the Sleep-wake Cycle Modulation. A Tentative Approach for Treatment of Sleep Disorders.

44. Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα.

45. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.

46. Conjugated linoleic acids influence fatty acid metabolism in ovine ruminal epithelial cells.

47. PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption.

48. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.

49. Dose and Effect Thresholds for Early Key Events in a PPARα-Mediated Mode of Action.

50. Pathway Based Toxicology and Fit-for-Purpose Assays.

Catalog

Books, media, physical & digital resources